Cost-effectiveness analysis of pharmaceutical care for hypertensive patients from the perspective of the public health system in Brazil.
Maurílio de Souza CazarimLeonardo Régis Leira PereiraPublished in: PloS one (2018)
Even for the highest ICER, the values were below the cost effectiveness threshold, which means that PC was a cost effective strategy for the care of hypertensive patients in the PHS.